BeStock  
Stocks › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #3180
$30.59 −$0.80 (-2.55%)
Pre-market · Oct 8, 7:00 am ET · After hours $29.99 -1.96%
Open$30.91
Prev close$31.39
Day range$30.53 – $31.75
Volume355.5K
Market cap$1.09B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.8x
CheapRich

Around its usual level · 53rd percentile, 5-year average -6.4x

Price / book6.5x
CheapRich

Above its usual level · 66th percentile, 5-year average 5.2x

#4559 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-11x-7x-3x1xApr '26Jul '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$30.83
Price vs. fair value-0.8%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.48 – 5.19 66% (pricier than usual) #4559 of 5317 (1 = cheapest)
PE -6.75 -8.19 -6.35 53% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$30.83
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on TRAX.

Leave a comment

Scroll to Top